Elliot Krames
Overview
Explore the profile of Elliot Krames including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Czura C, Bikson M, Charvet L, Chen J, Franke M, Fudim M, et al.
Front Neurol
. 2022 Aug;
13:897124.
PMID: 35911909
Since the outbreak of the COVID-19 pandemic, races across academia and industry have been initiated to identify and develop disease modifying or preventative therapeutic strategies has been initiated. The primary...
2.
Amirdelfan K, Gliner B, Kapural L, Sitzman B, Vallejo R, Yu C, et al.
Postgrad Med
. 2019 Mar;
131(4):278-286.
PMID: 30901266
: In the treatment of chronic diseases, remission is commonly used as a meaningful treatment goal, synonymous with the absence of significant clinical signs and symptoms of a disease, but...
3.
Deer T, Provenzano D, Hanes M, Pope J, Thomson S, Russo M, et al.
Neuromodulation
. 2017 Jan;
20(1):31-50.
PMID: 28042909
Introduction: The use of neurostimulation for pain has been an established therapy for many decades and is a major tool in the arsenal to treat neuropathic pain syndromes. Level I...
4.
Deer T, Hayek S, Pope J, Lamer T, Hamza M, Grider J, et al.
Neuromodulation
. 2017 Jan;
20(2):133-154.
PMID: 28042906
Introduction: Intrathecal (IT) drug infusion is an appropriate and necessary tool in the algorithm to treat refractory cancer and noncancer pain. The decision-making steps/methodology for selecting appropriate patients for implanted...
5.
Deer T, Pope J, Hayek S, Bux A, Buchser E, Eldabe S, et al.
Neuromodulation
. 2017 Jan;
20(2):96-132.
PMID: 28042904
Introduction: Pain treatment is best performed when a patient-centric, safety-based philosophy is used to determine an algorithmic process to guide care. Since 2007, the International Neuromodulation Society has organized a...
6.
Deer T, Krames E, Mekhail N, Pope J, Leong M, Stanton-Hicks M, et al.
Neuromodulation
. 2014 Aug;
17(6):599-615.
PMID: 25112892
Introduction: The International Neuromodulation Society (INS) has determined that there is a need to provide an expert consensus that defines the appropriate use of neuromodulation technologies for appropriate patients. The...
7.
Deer T, Mekhail N, Provenzano D, Pope J, Krames E, Thomson S, et al.
Neuromodulation
. 2014 Aug;
17(6):571-97.
PMID: 25112891
Introduction: The International Neuromodulation Society (INS) has determined that there is a need for guidance regarding safety and risk reduction for implantable neurostimulation devices. The INS convened an international committee...
8.
Deer T, Mekhail N, Petersen E, Krames E, Staats P, Pope J, et al.
Neuromodulation
. 2014 Aug;
17(6):551-70.
PMID: 25112890
Introduction: The International Neuromodulation Society (INS) has identified a need for evaluation and analysis of the practice of neurostimulation of the brain and extracranial nerves of the head to treat...
9.
Deer T, Mekhail N, Provenzano D, Pope J, Krames E, Leong M, et al.
Neuromodulation
. 2014 Aug;
17(6):515-50.
PMID: 25112889
Introduction: The Neuromodulation Appropriateness Consensus Committee (NACC) of the International Neuromodulation Society (INS) evaluated evidence regarding the safety and efficacy of neurostimulation to treat chronic pain, chronic critical limb ischemia,...
10.
Durand D, Ghovanloo M, Krames E
J Neural Eng
. 2014 Feb;
11(2):020201.
PMID: 24503546
No abstract available.